Effect of interleukin-28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with pegylated interferon alpha-2a/ribavirin.

Pearlman Brian L, Ehleben Carole

Hepatology. 2012 May;55(5):1645. doi: 10.1002/hep.25552.

Abstract

摘要

相似文献

Hepatology. 2012 May;55(5):1645. doi: 10.1002/hep.25552.

Pharmacogenet Genomics. 2015 Sep;25(9):465-74. doi: 10.1097/FPC.0000000000000158.

J Gastroenterol Hepatol. 2008 Jun;23(6):861-6. doi: 10.1111/j.1440-1746.2008.05397.x. Epub 2008 Apr 19.

Gene. 2013 Jun 10;522(1):121. doi: 10.1016/j.gene.2013.03.013. Epub 2013 Mar 16.

Hepatology. 2013 Mar;57(3):870-2. doi: 10.1002/hep.26026.

Liver Int. 2011 Mar;31(3):401-11. doi: 10.1111/j.1478-3231.2010.02435.x. Epub 2011 Jan 11.

J Gastroenterol Hepatol. 2007 May;22(5):645-52. doi: 10.1111/j.1440-1746.2007.04834.x.

N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047.

J Med Virol. 2010 Dec;82(12):2027-31. doi: 10.1002/jmv.21909.

J Gastroenterol Hepatol. 2007 May;22(5):669-75. doi: 10.1111/j.1440-1746.2007.04898.x.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。